Issue - meetings

Purpose of report:

a)    To present the Surrey Pharmaceutical Needs Assessment (PNA), highlighting key aspects of the PNA including its recommendations to the Health and Wellbeing Board (HWB)

b)    To ask the HWB to ratify the PNA following the Chair’s Action to approve publication on 1st April 2018 in accordance with the requirements of the NHS (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013.

Declarations of interest:

None

Witnesses:

Julie George, Public Health Consultant

Key points raised during the discussion:

1. The board noted a change to the running order of the agenda, upon officers request the Chairman agreed to review item 11 before the STP update.

2. It was highlighted that the Pharmaceutical Needs Assessment (PNA) was a statutory responsibility of the Health & Wellbeing Board (H&WB) and was due to be published on 1 April 2018. 

3. It was noted as the March H&WB meeting was cancelled the chairs approved the publication as a chairs action and sought the Board’s ratification of this decision in public in its meeting today.

4. The Board received a presentation (attached as Annex 1) on the Surrey Pharmaceutical Needs Assessment (PNA), highlighting key aspects of the PNA including its recommendations to the Health and Wellbeing Board.

5. There was a discussion around pharmacy opening hours and how this impacted the discharge of patients, the Board were assured that pharmacy opening hours did not affect patients being transferred out of hospital as opening hours only applied to the public.

6. It was explained that delays in discharging patients was mainly due to the process and not the dispensing of medicines. CCG’s noted this concern and agreed to consider advising departments to communicate better.

7. The Board also agreed that improved signposting could relieve GP surgeries and hospitals with patients as treatments were more commonly available at pharmacies. The Board noted that they would like a future item relating to pharmacies and the health and social care system at a future meeting.

8. It was noted that Martin Mandelbaum has now retired as Chief Executive of the Surrey Local Pharmaceutical Committee after many years of service and was commended for providing constructive challenge and insight to the Health and Wellbeing Board and his contribution on the two Pharmaceutical Needs Assessments for Surrey.

Actions/ further information to be provided:

Officers to include an item on pharmacies and the health and social care system on the Board’s forward plan.

RESOLVED:

The Board approved the PNA publications on 1 April 2018 and supported the following recommendations;

Recommendations 1

a)    Recognise the potential for population growth with large scale housing developments

b)    Partners to consider how to improve access to enhanced services in rural and deprived areas

c)    Improve signposting to existing pharmaceutical services

d)    Improve inter-professional contact

Recommendation 2

Local Clinical Commissioning Groups and the STPs should consider the findings and recommendations of this PNA in the course of their on-going work to improve the health of the local population, implement the GPFV and improve urgent and unplanned care services.

Purpose of report:

a)    To present the Surrey Pharmaceutical Needs Assessment (PNA), highlighting key aspects of the PNA including its recommendations to the Health and Wellbeing Board (HWB)

b)    To ask the HWB to approve the PNA in readiness for its publication by 1st April 2018 in accordance with the requirements of the NHS (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013.